Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Oliver F. W. Gardner"'
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/8f6ca529954f4d4cb32bad85e4132614
Autor:
Neil W. Bulstrode, Naiara Rodriguez-Florez, David Dunaway, Alessandro Borghi, Sophie E.P. New, Oliver F W Gardner, Amel Ibrahim, Patrizia Ferretti, Eleonora Zucchelli
Publikováno v:
Stem Cells Translational Medicine
While human adipose‐derived stem cells (hADSCs) are known to possess osteogenic differentiation potential, the bone tissues formed are generally considered rudimentary and immature compared with those made by bone‐derived precursor cells such as
Autor:
Alexander J Neumann, Oliver F W Gardner, Rebecca Williams, Mauro Alini, Charles W Archer, Martin J Stoddart
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136229 (2015)
Articular cartilage progenitor cells (ACPCs) represent a new and potentially powerful alternative cell source to commonly used cell sources for cartilage repair, such as chondrocytes and bone-marrow derived mesenchymal stem cells (MSCs). This is part
Externí odkaz:
https://doaj.org/article/b70cf51a8084440881acf2177b6a9a57
Autor:
Jos Malda, Lewis Francis, Oliver F W Gardner, Charles W. Archer, Guillermo Bauza-Mayol, Ilyas M. Khan, Riccardo Levato, René van Weeren, Ben J. Morgan, Yadan Zhang, R.S. Conlan
Publikováno v:
Stem Cells and Development
Articular cartilage contains a subpopulation of tissue-specific progenitors that are an ideal cell type for cell therapies and generating neocartilage for tissue engineering applications. However, it is unclear whether the standard chondrogenic mediu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3bd625dcb2c8ce35d25bbe53980eaf9
https://cronfa.swan.ac.uk/Record/cronfa54205/Download/54205__17452__dc8677f3cbc245e7bcb440ba26e3a4d3.pdf
https://cronfa.swan.ac.uk/Record/cronfa54205/Download/54205__17452__dc8677f3cbc245e7bcb440ba26e3a4d3.pdf
Publikováno v:
Tissue Engineering Part A. 24:849-859
Mesenchymal stem cells (MSCs) are considered a promising cell source for cartilage repair strategies due to their chondrogenic differentiation potential. However, their in vitro tendency to progress toward hypertrophy limits their clinical use. This
Autor:
Patrizia Ferretti, Atheer Ujam, Estephania Candelo Gomez, Neil W. Bulstrode, Oliver F W Gardner, Natacha Agabalyan
Publikováno v:
British Journal of Oral and Maxillofacial Surgery. 57:e88-e89
Publikováno v:
Journal of Tissue Engineering and Regenerative Medicine. 11:2663-2666
Transforming growth factor-β1 (TGF-β1) is widely used in an active recombinant form to stimulate the chondrogenic differentiation of mesenchymal stem cells (MSCs). Recently, it has been shown that the application of multiaxial load, that mimics the
Autor:
Alexander J. Neumann, Charles W. Archer, Mauro Alini, David Eglin, Giuseppe Musumeci, Martin J. Stoddart, Oliver F. W. Gardner
Publikováno v:
Journal of Tissue Engineering and Regenerative Medicine. 11:2912-2921
Mesenchymal stem cells (MSCs) are currently being investigated as candidate cells for regenerative medicine approaches for the repair of damaged articular cartilage. For these cells to be used clinically, it is important to understand how they will r
Publikováno v:
European Cells & Materials, Vol 31, Pp 221-235 (2016)
European cells & materials
European cells & materials
Mesenchymal stem cells (MSCs) can be induced towards chondrogenesis through the application of chondrogenic stimuli such as transforming growth factor-β (TGF-β) or by multiaxial mechanical load. Previous work has showed that the chondrogenic effect
Autor:
Henning Madry, Ana Rey-Rico, Mauro Alini, Magali Cucchiarini, Oliver F. W. Gardner, David Eglin, Martin J. Stoddart, Jagadeesh K. Venkatesan
Publikováno v:
International Journal of Molecular Sciences
Volume 19
Issue 9
International Journal of Molecular Sciences, Vol 19, Iss 9, p 2635 (2018)
Volume 19
Issue 9
International Journal of Molecular Sciences, Vol 19, Iss 9, p 2635 (2018)
The repair of focal articular cartilage defects remains a problem. Combining gene therapy with tissue engineering approaches using bone marrow-derived mesenchymal stem cells (MSCs) may allow the development of improved options for cartilage repair. H